Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

UK shows multi-stakeholder approach tackles diversity

The UK has been seriously tackling the issue of diversity in the senior ranks of British business. The Davies Review, led by the charismatic but challenging Lord Mervyn Davies, pushed UK boards to get 25% of women on the boards … Continue reading

Posted in Corporate Governance, Workplace Diversity | Tagged , , , , , , , , , , , , , , , , , , , | Leave a comment

Five Resolutions for Nominations Committees to Improve Board Performance

The New Year brings a period of reflection, what will you change in the year ahead and how will you do it? There are some clear ways in which the effectiveness of the board can be improved by the way … Continue reading

Posted in Corporate Governance | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Kuros Biosurgery Closes Round at CHF 20m

Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products and focused in therapeutic areas covering sealants and orthobiologics, today announces that it has raised an additional CHF 5 million in a fully subscribed second closing of … Continue reading

Posted in M&A Finance and Funding | Tagged , , , , , , | Leave a comment

Sara Mathew further diversifies Shire’s Board

Shire plc has appointed Sara Mathew to its Board of Directors as a Non-Executive Director. Sara will also be a member of the Audit, Compliance & Risk Committee of the Shire Board. Both appointments will be effective as of September 1, 2015. … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , , , | Leave a comment

Shire goes hostile on Baxter spin-out Baxalta

Fresh from announcing that the company will acquire Foresight BioTherapeutics for $300m (here), Shire stepped up its ambitions to acquire the recently spun-out Baxalta, which went public earlier this summer (here). Shire originally approached the Baxalta Board of Directors earlier … Continue reading

Posted in M&A Finance and Funding | Tagged , , , , , , , , , , , , | Leave a comment

MorphoSys partners to access GPCR-Targeting tech

MorphoSys based out of Munich and G7 Therapeutics AG of Zurich announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors (GPCRs) and potentially other disease-related transmembrane proteins such as ion channels. … Continue reading

Posted in Pharmaceutical business | Tagged , , , , | Leave a comment

Shire Eyes Smaller Deal in Shopping Spree

In the recent analyst call for Shire’s Q2 results, CEO Flemming Ornskov suggested that the company was still scouting for acquisitions which would bolster the pipeline in the strategic areas he has set out as priorities. Cognizant that valuations are … Continue reading

Posted in M&A Finance and Funding | Tagged , , , , , , | Leave a comment

M&A Continues to Dominate the Rare Diseases Landscape

Alexion took everyone by surprise in recent weeks by announcing a very sizable acquisition of Boston-based Synageva for $8.4bn. This was a significant deal which will only serve to strengthen valuations of rare disease biotechnology companies, which continue to be … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Biotechnology must embrace a more diverse future of leadership

Authored by Karl Simpson When you talk to biotech entrepreneurs and sector investors, the topic of management and leadership is one that often features very strongly as the critical success factor. However, there is a dearth of research analysis into … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Executive Recruitment Roundup – September 2014

Authored by Karl Simpson Genocea Biosciences, a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Kenneth Bate has joined the company’s board of directors.  He currently is chairman of the board of Cubist Pharmaceuticals, Inc., and … Continue reading

Posted in Executive Appointments, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap